Back

Improved ejection fraction following optimised treatment for heart failure with reduced ejection fraction in a patient with dilated cardiomyopathy and TNNT2 mutation

19 May 2025 (09:00 - 09:15)
Organised by: Logo
Congress Presentation Part of: Effecting one’s future treatment in chronic heart failure Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Bianca Fernandes Tavora Arruda

Dante Pazzanese Institute of Cardiology, Sao Paulo (Brazil)

2 More presentations in this session

Presentation thumbnail
How did a three-year tafamidis therapy course affect our patient's life?
Doctor N. Gataric (Belgrade, RS)
Slides Video
Presentation thumbnail
Sacubitril/valsartan dose escalation in a patient with low blood pressure and a history of orthostatic syncope under controlled remote monitoring of vital signs
Doctor A. Drohomirecka (Warsaw, PL)
Slides Video

Access the full session

Session thumbnail
Effecting one’s future treatment in chronic heart failure
Video

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
A complex journey - from hypertrophic to dilated cardiomyopathy: the evolving cardiac phenotype in a genetically predisposed patient
thumbnail
Congress Presentation
Beyond acute decompensated heart failure: a genotype-guided approach in dilated cardiomyopathy
thumbnail
Congress Session
Genetic dilated cardiomyopathy: beyond one phenotype

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources